Perrigo Laboratories India Private Limited, a converted to llp private limited company, was established on 23 February 2005 in Thane, Maharashtra, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24230MH2005PTC240217. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.21 M.
It upholds a compliant status. Employing 25 professional, Its leadership includes Sumedha Nadkar Sanjeev (Whole-Time Director), James Edwin Dillard Iii (Director). Past directors included Sumedha Nadkar Sanjeev, Sharon Gershon Kochan, James Edwin Dillard Iii. It holds no open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Bldg No. 8, Flat 004, Kailash Nagar, Wadavli Section, India, Ambernath, Maharashtra, 421501.
U24230MH2005PTC240217
240217
23 February 2005
₹1.00 M
₹0.21 M
Roc Mumbai
Unlisted
Converted to LLP
Explore comprehensive insights into Perrigo Laboratories India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumedha Nadkar Sanjeev | Whole-Time Director | 30 Sep 2015 | Current |
| James Edwin Dillard Iii | Director | 21 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Feb 2015 | Past |
| Pramod Abcsdd | Director | 25 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Director | 18 Dec 2015 | Past |
| Pramod Abcsdd | Director | 02 Jun 2016 | Past |
| Pramod Abcsdd | Director | 22 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Perrigo Laboratories India Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.24% decrease. The company also saw a substantial fall in profitability, with a 19.98% decrease in profit. The company's net worth moved up by a moderate rise of 7.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Perrigo Laboratories India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2014 | The Hongkong And Shanghai Banking Corporation Limited | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Perrigo Laboratories India has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Perrigo Laboratories India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Perrigo Laboratories India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 21 Nov 2014 via Charge ID 10544514 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 30 Nov 2022. was documented.
Progress on Perrigo Laboratories India Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Perrigo Laboratories India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was recorded as a recent event.
The activity James Edwin Dillard Iii was appointed as a Director was appointed as a Director on 21 Sep 2020 & has been associated with this company since 5 years 3 months . was completed.
Sumedha Nadkar Sanjeev was appointed as a Whole-time director was appointed as a Whole-time director on 30 Sep 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.
Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 5.00 M with Charge ID 10544514 was registered on 21 Nov 2014. was documented.
The US FDA-approved facility, located at Ambernath in Maharashtra, has an annual capacity to produce 600 tonnes of active pharmaceuticals ingredient.
The CIN of Perrigo Laboratories India Private Limited is U24230MH2005PTC240217.
Perrigo Laboratories India Private Limited is headquartered at Bldg No. 8, Flat 004, Kailash Nagar, Wadavli Section, India, Ambernath, Maharashtra, 421501.
Perrigo Laboratories India Private Limited was incorporated on 23 February 2005.
The current directors of Perrigo Laboratories India Private Limited are
The primary industry of Perrigo Laboratories India Private Limited is Professional, Scientific And Technical.
Perrigo Laboratories India Private Limited is unlisted.
The authorized capital of Perrigo Laboratories India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.21 M.
The compliance status of Perrigo Laboratories India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX